Barry Flannelly
About Barry Flannelly
Barry P. Flannelly, PharmD, MBA, is the Executive Vice President and General Manager for North America at Incyte, with a career spanning over three decades in the oncology sector of the pharmaceutical and biotech industry.
Barry P. Flannelly's Current Role at Incyte
Barry P. Flannelly is the Executive Vice President and General Manager for North America at Incyte. He joined the company in 2014 as Executive Vice President of Business Development and Strategic Planning. In 2015, he was appointed the role of General Manager, US, where he has been central in overseeing operations within the United States.
Barry P. Flannelly's Career in Oncology
Since 1987, Barry P. Flannelly has been actively involved in the field of oncology. His extensive career in oncology includes positions in reputable companies such as Rhone-Poulenc Rorer, which later became Sanofi-Aventis, Novartis Pharmaceuticals Corporation, Abraxis Oncology, Onyx Pharmaceuticals, Inc., and Nektar Therapeutics. These roles have given him a broad and deep understanding of the oncology sector.
Barry P. Flannelly's Pharmaceutical Industry Background
Barry P. Flannelly began his career in the pharmaceutical and biotech industry at Rhone-Poulenc Rorer, which later transitioned to Sanofi-Aventis. Over the years, he took on roles of increasing responsibility, contributing to significant areas like medical affairs, strategic planning, and commercial operations. His past positions included titles such as Head of Sales and Marketing and Head of Business Development.
Barry P. Flannelly's Educational Background
Barry P. Flannelly holds a Doctor of Pharmacy from the University of Maryland School of Pharmacy and a Master of Business Administration from the University of Baltimore. Additionally, he earned his Bachelor of Science in Pharmacy from Massachusetts College of Pharmacy. This diverse educational background equips him with a robust foundation in both pharmacy and business administration.